Xencor (XNCR) Total Debt (2023 - 2026)
Xencor (XNCR) reported Total Debt of $108.5 million for Q1 2026, down 29.7% year-over-year from $154.4 million in Q1 2025, and down 9.37% quarter-over-quarter from $119.7 million in Q4 2025.
Xencor (XNCR) Total Debt (2023 - 2026) Analysis & Trends
Xencor (XNCR) has 4 years of Total Debt data on file, last reported at $108.5 million in Q1 2026.
- Total Debt for Q1 2026 came in at $108.5 million, down 29.7% year-over-year; the trailing twelve-month figure through Mar 2026 was $108.5 million (down 29.7% YoY), and the FY2025 annual result was $119.7 million, down 26.81% from the prior year.
- Total Debt fell to $108.5 million in Q1 2026 per XNCR's latest filing, from $119.7 million in the prior quarter.
- Over five years, Total Debt peaked at $189.5 million in Q4 2023 and troughed at $108.5 million in Q1 2026.
- A 4-year average of $155.2 million and a median of $159.0 million in 2024 frame the typical range for Total Debt.
- The sharpest annual moves came in 2024 and 2026: Total Debt fell 13.66% in 2024, then retreated 29.7% in 2026.
- A 4-year view of Total Debt shows it stood at $189.5 million in 2023, then declined by 13.66% to $163.6 million in 2024, then fell by 26.81% to $119.7 million in 2025, then declined by 9.37% to $108.5 million in 2026.
- Business Quant data shows XNCR's Total Debt at $108.5 million in Q1 2026, $119.7 million in Q4 2025, and $133.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 319.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Xencor | 953.38 Mn | 878.64 Mn | - | 108.53 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 108.53 Mn |
| Dec 31, 2025 | 119.75 Mn |
| Sep 30, 2025 | 133.14 Mn |
| Jun 30, 2025 | 145.02 Mn |
| Mar 31, 2025 | 154.38 Mn |
| Dec 31, 2024 | 163.61 Mn |
| Sep 30, 2024 | 172.80 Mn |
| Jun 30, 2024 | 179.76 Mn |
| Mar 31, 2024 | 185.10 Mn |
| Dec 31, 2023 | 189.48 Mn |